spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

14th Annual Biomarkers & Immuno-Oncology World Congress

Biomarkers and Immuno-Oncology World Congress

11-13 June 2018
Westin Boston Waterfront, Boston, Massachusetts

Cambridge Healthtech Institute's Fourteenth Annual Biomarkers and Immuno-Oncology World Congress, now in Boston, is our longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. With the promising developments in immuno-oncology over the past years, much of the biomarker R&D has shifted to discovery and development of predictive biomarkers for immunotherapy patient stratification, using biomarkers to choose rational combination immunotherapy, and applying immune profiling to predict and monitor response to immunotherapy. The Immuno-Oncology Biomarkers stream will address predictive biomarkers and companion diagnostics, as well as immune profiling and immune monitoring. The Immunotherapy stream will address the two biggest challenges in pharmaceutical IO programs: designing rational combination immunotherapies and strategies to address intrinsic and acquired resistance. Finally, a new track on Digital Biomarkers will cover the clinical utility of biosensors, wearables and mobile health, and their emerging applications in drug development.

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its fourteenth year, the Biomarkers and Immuno-Oncology World Congress is the leading annual meeting dedicated to biomarkers, diagnostics, and immuno-oncology research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.

Please join us in Boston for comprehensive scientific coverage and unparalleled networking opportunities at the Fourteenth Annual Biomarkers and Immuno-Oncology World Congress 2018!

Visit the event page often for updates: www.BiomarkerWorldCongress.com

-Contact Details 

Cambridge Healthtech Institute

250 First Avenue, Suite 300

Needham, MA 02494

T: 781-972-5400

F: 781-972-5425

E: chi@healthtech.com

www.healthtech.com

 

phone 781-972-5400
email chi@healthtech.com
web www.BiomarkerWorldCongress.com
email Westin Boston Waterfront, Boston, Massachusetts
 
Print this page
Send to a friend
   
spacer
Industry Events

Pharmaceutical Packaging and Device Labelling Europe

11-12 September 2018, Munich, Germany

Relaunching the event after a three year hiatus, Pharma Packaging and Labelling Europe is back to deliver key, actionable insight on the very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into your packaging and labelling chain with both maximum efficiency and minimal cost. The conference is packed with thought provoking innovative discussions.
More info >>

Banner of PHPL West Coast_events_95 on Samedan Banner of Nordics_Events_97 on Samedan

White Papers

Extractables and Leachables Testing: A Risk Based Approach

RSSL

Pharmaceutical products are in contact with many external components during both manufacture and usage and small amounts of chemicals may leach from these components with a potential health risk to the patient. Extractables and leachables (E&L) studies therefore play an important role in verifying the safety of a drug product over its lifetime. Regulatory organisations such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) are taking an increased interest in the interactions of various drug delivery devices, pharmaceutical product containers and medical devices with drug product and/or patient and this field is therefore growing in importance. Regulatory guidelines indicate that an extractables profile should be determined for all materials that contact the drug product. Once established, this profile can be used to determine whether any of these extractables are present as leachables within the product. If a leachable is detected, amounts can be determined using validated analytical methods, after which a biological risk can be established based on the exposure. This white paper will provide an overview of the processes used to determine extractables and leachables from plastics.
More info >>


News and Press Releases

New to the PPMA Show 2018: Bright Ideas - Ambassador Programme

A new initiative for PPMA Show visitors this year is the Bright Ideas - Ambassador Programme - a free advice service for start-up ventures and entrepreneurs.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement